Transfection of the c-myc oncogene into normal Epstein-Barr virus-harboring B cells results in new phenotypic and functional features resembling those of Burkitt lymphoma cells and normal centroblasts - PubMed (original) (raw)
Transfection of the c-myc oncogene into normal Epstein-Barr virus-harboring B cells results in new phenotypic and functional features resembling those of Burkitt lymphoma cells and normal centroblasts
G Cutrona et al. J Exp Med. 1995.
Abstract
Activated c-myc gene was introduced into the cells of three normal Epstein-Barr virus (EBV)-positive lymphoblastoid B cell lines (LCL). The cells were monitored for the appearance of new phenotypic and functional features compared with the control LCL cells transfected with plasmid that did not contain the c-myc gene. The LCL-expressing c-myc constitutively did not arrest growth in low serum concentration. However, the cell number in the cultures failed to increase because of substantial cell death. Death was due to apoptosis as demonstrated by flow cytometric analysis of propidium iodide-stained cells, by typical DNA laddering in gel electrophoresis, and by the inspection of Giemsa-stained cell smears. Apoptosis was also induced by exposing the transfected cells to antibodies directed to the immunoglobulin mu chain (a-mu-ab) irrespective of the serum concentration in the culture. Exposure of the cells to CD40 ligand (CD40L) or CD40 monoclonal antibody prevented cell apoptosis. Upon transfection with c-myc, the LCL cells acquired a vacuolated morphology that was never observed in control cells. Moreover, the expression of CD10 and CD38 was upregulated, while that of CD39 and especially CD23 was downregulated. Unlike that observed in certain Burkitt lymphoma (BL) cell lines that share the same surface phenotype (CD10+CD38+CD23-CD39-), the c-myc-transfected cells expressed lymphocyte function-associated (LFA) 1, LFA-3, and intercellular adhesion molecule 1 and grew in large clumps rather than single-cell layers. Expression of CD10 and CD38 was particularly evident on the cells undergoing apoptosis, thus suggesting a correlation between the presence of these markers and the apoptotic process. Cells placed in conditions favoring in vitro apoptosis displayed downregulation of Bcl-2 protein. Bcl-2 expression was, however, upregulated when the cells were exposed to CD40L. These data indicate that the B cells expressing c-myc constitutively acquire some of the features of normal centroblasts and of BL cells, including the expression of CD10 and CD38, and the propensity to undergo apoptosis, which can be prevented by exposure to CD40L. Therefore, these cells can serve as a model system to study both BL lymphomagenesis as well as the process of B cell selection occurring in the germinal centers.
Similar articles
- Antagonistic effects of c-myc and Epstein-Barr virus latent genes on the phenotype of human B cells.
Pajic A, Staege MS, Dudziak D, Schuhmacher M, Spitkovsky D, Eissner G, Brielmeier M, Polack A, Bornkamm GW. Pajic A, et al. Int J Cancer. 2001 Sep;93(6):810-6. doi: 10.1002/ijc.1404. Int J Cancer. 2001. PMID: 11519042 - A phenotypic study of cells from Burkitt lymphoma and EBV-B-lymphoblastoid lines and their relationship to cells in normal lymphoid tissues.
Ling NR, Hardie D, Lowe J, Johnson GD, Khan M, MacLennan IC. Ling NR, et al. Int J Cancer. 1989 Jan 15;43(1):112-8. doi: 10.1002/ijc.2910430122. Int J Cancer. 1989. PMID: 2536003 - The A-myb gene is preferentially expressed in tonsillar CD38+, CD39-, and sIgM- B lymphocytes and in Burkitt's lymphoma cell lines.
Golay J, Erba E, Bernasconi S, Peri G, Introna M. Golay J, et al. J Immunol. 1994 Jul 15;153(2):543-53. J Immunol. 1994. PMID: 8021494 - Epstein-Barr virus (EBV) and human hematopoietic cell lines: a review.
Tatsumi E. Tatsumi E. Hum Cell. 1992 Mar;5(1):79-86. Hum Cell. 1992. PMID: 1329932 Review. - c-MYC impairs immunogenicity of human B cells.
Schlee M, Schuhmacher M, Hölzel M, Laux G, Bornkamm GW. Schlee M, et al. Adv Cancer Res. 2007;97:167-88. doi: 10.1016/S0065-230X(06)97007-9. Adv Cancer Res. 2007. PMID: 17419945 Review.
Cited by
- Old and New Facts and Speculations on the Role of the B Cell Receptor in the Origin of Chronic Lymphocytic Leukemia.
Bagnara D, Mazzarello AN, Ghiotto F, Colombo M, Cutrona G, Fais F, Ferrarini M. Bagnara D, et al. Int J Mol Sci. 2022 Nov 17;23(22):14249. doi: 10.3390/ijms232214249. Int J Mol Sci. 2022. PMID: 36430731 Free PMC article. Review. - CD10 expression in urothelial carcinoma of the bladder.
Bahadir B, Behzatoglu K, Bektas S, Bozkurt ER, Ozdamar SO. Bahadir B, et al. Diagn Pathol. 2009 Nov 16;4:38. doi: 10.1186/1746-1596-4-38. Diagn Pathol. 2009. PMID: 19917108 Free PMC article. - MYC Controls the Epstein-Barr Virus Lytic Switch.
Guo R, Jiang C, Zhang Y, Govande A, Trudeau SJ, Chen F, Fry CJ, Puri R, Wolinsky E, Schineller M, Frost TC, Gebre M, Zhao B, Giulino-Roth L, Doench JG, Teng M, Gewurz BE. Guo R, et al. Mol Cell. 2020 May 21;78(4):653-669.e8. doi: 10.1016/j.molcel.2020.03.025. Epub 2020 Apr 20. Mol Cell. 2020. PMID: 32315601 Free PMC article. - Differential tumorigenicity between Epstein-Barr virus genome-positive and genome-negative cell lines with t(11;14)(q13;q32) derived from mantle cell lymphoma.
Daibata M, Kubonishi I, Miyoshi I. Daibata M, et al. J Virol. 1996 Dec;70(12):9003-7. doi: 10.1128/JVI.70.12.9003-9007.1996. J Virol. 1996. PMID: 8971032 Free PMC article. - In vivo Screen Identifies Zdhhc2 as a Critical Regulator of Germinal Center B Cell Differentiation.
Zhao R, Zhang H, Zhang Y, Li D, Huang C, Li F. Zhao R, et al. Front Immunol. 2020 Jun 10;11:1025. doi: 10.3389/fimmu.2020.01025. eCollection 2020. Front Immunol. 2020. PMID: 32587588 Free PMC article.
References
- J Histochem Cytochem. 1978 Nov;26(11):921-33 - PubMed
- Cell. 1991 Jun 28;65(7):1107-15 - PubMed
- Nature. 1985 May 16-22;315(6016):190-5 - PubMed
- Annu Rev Immunol. 1986;4:317-38 - PubMed
- Oncogene. 1991 Oct;6(10):1915-22 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials